SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: EX-1.1
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/ex1-1.htm

Chunk 15 of 21
Word Count: 1102
Character Count: 6863

Document Content:

Package and the Prospectus, addressed to the Representative and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of this Agreement and with a specified date therein not more than two (2) Business Days prior to the date of this Agreement. Bring-down Comfort Letter. At the Closing Date and at any Option Closing Date, the Representative shall have received from the Auditor a letter, dated as of the Closing Date or the applicable Option Closing Date, to the effect that the Auditor reaffirms the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a date no earlier than the later of (i) the date of this Agreement and (ii) the date that is two (2) Business Days prior to the Closing Date or the applicable Option Closing Date. Officers’ Certificates.

Officers’ Certificate. The Company shall have furnished to the Representative a certificate, dated the Closing Date and
any Option Closing Date, of its Chief Executive Officer and its Chief Financial Officer on behalf of the Company and not in an individual
capacity stating that (i) such officers have carefully examined the Registration Statement, the Pricing Disclosure Package and the Prospectus
and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date and
any Option Closing Date did not include any untrue statement of a material fact and did not omit to state a material fact required to
be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading,
and the Pricing Disclosure Package, as of the Applicable Time and as of the Closing Date and any Option Closing Date, the Prospectus
and each amendment or supplement thereto, as of the respective date thereof and as of the Closing Date and any Option Closing Date, did
not include any untrue statement of a material fact and did not omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances in which they were made, not misleading, (ii) since the effective date of the Registration Statement,
no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement, the Pricing Disclosure
Package or the Prospectus, (iii) to the best of their knowledge after reasonable investigation, as of the Closing Date and any Option
Closing Date, the representations and warranties of the Company in this Agreement are true and correct and the Company has complied with
all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and any
Option Closing Date, and (iv) there has not been, subsequent to the date of the most recent audited financial statements included or
incorporated by reference in the Pricing Disclosure Package, any Material Adverse Change, except as set forth in the Prospectus.

Secretary’s Certificate. At the Closing Date and at any Option Closing Date, the Representative shall have received a certificate
of the Company signed by the Secretary (or the Chief Financial Officer in lieu of the Secretary) of the Company, dated the Closing Date
and the applicable Option Closing Date, certifying: (i) that the Company’s certificate of incorporation and bylaws are true and
complete, have not been modified and are in full force and effect; (ii) that the resolutions of the Company’s Board of Directors
relating to the Offering are in full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence
between the Company or its counsel and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred
to in such certificate shall be attached to such certificate.

No Material Changes. Prior to and on the Closing Date and any Option Closing Date: (i) there shall have been no Material Adverse
Change in the condition or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition
is set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus; (ii) no action, suit or proceeding, at
law or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or federal or state
commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may reasonably be expected to cause
a Material Adverse Change, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus; (iii)
no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by
the Commission; and (iv) the Registration Statement, the Pricing Disclosure Package and the Prospectus and any amendments or supplements
thereto shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the Securities
Act Regulations and shall conform in all material respects to the requirements of the Securities Act and the Securities Act Regulations,
and neither the Registration Statement, the Pricing Disclosure Package nor the Prospectus nor any amendment or supplement thereto shall
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading.

Delivery of Agreements and Representative’s Warrants.

Lock-Up Agreements. On or before the date of this Agreement, the Company shall have delivered to the Representative executed copies
of the Lock-Up Agreements from each of the persons listed in Schedule 3 hereto.

Representative’s Warrants. On the Closing Date and on any Option Closing Date, the Company shall have delivered to the Representative
an executed copy of the Representative’s Warrants.

Additional Documents. At the Closing Date and at any Option Closing Date, Representative Counsel shall have been furnished with
such documents and opinions as they may reasonably require for the purpose of enabling Representative Counsel to deliver an opinion to
the Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the
conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Shares,
the Representative’s Warrants and the Representative Warrant Shares as herein contemplated shall be reasonably satisfactory in
form and substance to the Representative and Representative Counsel.

Indemnification.

Indemnification of the Underwriters.